Established in 1977, Biomet is a family of companies that has enjoyed steady growth at levels exceeding market expansion. Biomet's performance demonstrates a responsive, customer-oriented approach to the health care market. Biomet thrives by strengthening its commitment to innovation and partnership.

Biomet prides itself on its unconventional profile:
the responsiveness and innovation of a small company,
with the resources and market presence of a large company.

Biomet, Inc. and its subsidiaries design, manufacture, and market products used primarily by musculoskeletal medical specialists in both surgical and non-surgical therapy. Biomet’s product portfolio encompasses reconstructive products, including orthopedic joint replacement devices, bone cements and accessories, autologous therapies and dental reconstructive implants; fixation products, including electrical bone growth stimulators, internal and external orthopedic fixation devices, craniomaxillofacial implants and bone substitute materials; spinal products, including spinal stimulation devices, spinal hardware and orthobiologics; and other products, such as arthroscopy products and softgoods and bracing products. Headquartered in Warsaw, Indiana, Biomet and its subsidiaries currently distribute products in approximately 90 countries.